Lung cancer patients with high AFAP1-AS1 expression levels presented with lymph node metastasis and advanced stage of disease, suggesting the relevance of AFAP1-AS1 up regulation in promoting lung cancer progression. Here, AFAP1 is linked to metastatic malignant neoplasm in the lymph nodes.